HCC risk remains after DAA-cured HCV in individuals with HIV, but the annual probability of developing HCC declines over 6 years.

Real-world evidence reinforces the effectiveness of nirsevimab in preventing severe respiratory syncytial virus-associated outcomes including intensive care unit admission and acute respiratory ...

Ablation therapy demonstrated comparable effectiveness for HCC in patients with hepatitis B-related recompensated vs compensated cirrhosis.

The higher prevalence of anti-tuberculosis drug-induced liver injury in patients with vs without hepatitis C virus (HCV) coinfection highlights the importance of routine HCV screening prior to ...

Cuba’s deputy health minister said that 33 people have died from chikungunya and dengue since July; 21 of the deaths were in children. HealthDay News — A severe mosquito-borne virus outbreak in Cuba ...

Dr Vinay Prasad, head of the FDA’s vaccine division, wrote in the memo that the deaths appeared to be tied to myocarditis, a rare type of heart inflammation that has been seen in some people after ...

Racial and ethnic disparities in pediatric COVID-19 severity were largest among hospitalized Black and Hispanic children with CCCs or government insurance.

In adults aged 18 to 64 years at increased risk for pneumococcal disease due to chronic conditions, the 21-valent pneumococcal conjugate vaccine (V116) is highly immunogenic and well-tolerated, ...

Bivalent RSV pre-F vaccine exhibited high effectiveness against RSV-associated hospitalization in older adults aged 75 to 79 years in England.

The 2024 to 2025 COVID-19 vaccine reduced the risk for ED visits, hospitalizations, and deaths among US veterans.